Nu-Med Plus (NUMD) EPS (Basic) Growth (1y) (2013 - 2025)
Nu-Med Plus (NUMD) EPS (Basic) Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 114.97% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -19.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.55% |
| Sep 30, 2025 | 37.62% |
| Jun 30, 2025 | 34.30% |
| Mar 31, 2025 | 8.67% |
| Dec 31, 2024 | 81.77% |
| Sep 30, 2024 | -13.84% |
| Jun 30, 2024 | 28.92% |
| Mar 31, 2024 | 24.65% |
| Dec 31, 2023 | -230.03% |
| Sep 30, 2023 | 72.30% |
| Jun 30, 2023 | 59.15% |
| Mar 31, 2023 | 53.88% |
| Dec 31, 2022 | 101.79% |
| Sep 30, 2022 | 51.20% |
| Jun 30, 2022 | 76.06% |
| Mar 31, 2022 | 83.29% |
| Dec 31, 2021 | -219.81% |
| Sep 30, 2021 | 83.48% |
| Jun 30, 2021 | 84.07% |
| Mar 31, 2021 | -36.63% |